Kimberly R. Jordan

Array ( [id] => 4143534 [patent_doc_number] => 06030979 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Pharmaceutical composition comprising 5,6-dihydrodibenzo[A,G] Quinolizinium derivatives and the salts thereof' [patent_app_type] => 1 [patent_app_number] => 9/235489 [patent_app_country] => US [patent_app_date] => 1999-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18873 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 290 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030979.pdf [firstpage_image] =>[orig_patent_app_number] => 235489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183596 [patent_doc_number] => 06020383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Method for reducing blood cholesterol and/or blood triglycerides' [patent_app_type] => 1 [patent_app_number] => 9/228092 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2107 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020383.pdf [firstpage_image] =>[orig_patent_app_number] => 228092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248559 [patent_doc_number] => 06136833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Pharmaceutical formulations and process for their preparation' [patent_app_type] => 1 [patent_app_number] => 9/228261 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7372 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136833.pdf [firstpage_image] =>[orig_patent_app_number] => 228261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235970 [patent_doc_number] => 06075058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Compositions for increased bioavailability of carotenoids' [patent_app_type] => 1 [patent_app_number] => 9/210468 [patent_app_country] => US [patent_app_date] => 1998-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 961 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075058.pdf [firstpage_image] =>[orig_patent_app_number] => 210468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185916 [patent_doc_number] => 06159993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Methods and compositions for the rapid and enduring relief of inadequate myocardial function' [patent_app_type] => 1 [patent_app_number] => 9/198874 [patent_app_country] => US [patent_app_date] => 1998-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8330 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159993.pdf [firstpage_image] =>[orig_patent_app_number] => 198874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4131969 [patent_doc_number] => 06034079 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Nicotine antagonists for nicotine-responsive neuropsychiatric disorders' [patent_app_type] => 1 [patent_app_number] => 9/198882 [patent_app_country] => US [patent_app_date] => 1998-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9133 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034079.pdf [firstpage_image] =>[orig_patent_app_number] => 198882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937666 [patent_doc_number] => 05976550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Dietary food supplement' [patent_app_type] => 1 [patent_app_number] => 9/196527 [patent_app_country] => US [patent_app_date] => 1998-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1672 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976550.pdf [firstpage_image] =>[orig_patent_app_number] => 196527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109092 [patent_doc_number] => 06057308 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Remedy or preventive for hyperlipemia' [patent_app_type] => 1 [patent_app_number] => 9/180745 [patent_app_country] => US [patent_app_date] => 1998-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2714 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057308.pdf [firstpage_image] =>[orig_patent_app_number] => 180745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4132704 [patent_doc_number] => 06034123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Method for altering blood lipid levels' [patent_app_type] => 1 [patent_app_number] => 9/193940 [patent_app_country] => US [patent_app_date] => 1998-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 939 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034123.pdf [firstpage_image] =>[orig_patent_app_number] => 193940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4223927 [patent_doc_number] => 06011049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Combinations for diabetes' [patent_app_type] => 1 [patent_app_number] => 9/189132 [patent_app_country] => US [patent_app_date] => 1998-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7905 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011049.pdf [firstpage_image] =>[orig_patent_app_number] => 189132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086192 [patent_doc_number] => 06162834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Foaming oil-in-water emulsion based on nonionic surfactants, a fatty phase and a crosslinked cationic or anionic polymer, and its use in topical applications' [patent_app_type] => 1 [patent_app_number] => 9/187036 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4285 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162834.pdf [firstpage_image] =>[orig_patent_app_number] => 187036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4115363 [patent_doc_number] => 06046184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Medicament for treating obesity and improving lipid metabolism' [patent_app_type] => 1 [patent_app_number] => 9/186158 [patent_app_country] => US [patent_app_date] => 1998-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 7166 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046184.pdf [firstpage_image] =>[orig_patent_app_number] => 186158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940274 [patent_doc_number] => 05981536 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Use of xanthine derivatives for the modulation of apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/175471 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5459 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981536.pdf [firstpage_image] =>[orig_patent_app_number] => 175471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938267 [patent_doc_number] => 05972973 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Sulfonylurea-glitazone combinations for diabetes' [patent_app_type] => 1 [patent_app_number] => 9/173911 [patent_app_country] => US [patent_app_date] => 1998-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6113 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972973.pdf [firstpage_image] =>[orig_patent_app_number] => 173911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934404 [patent_doc_number] => 05929091 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Method of lowering plasma levels of lipoprotein(a)' [patent_app_type] => 1 [patent_app_number] => 9/166678 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3465 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929091.pdf [firstpage_image] =>[orig_patent_app_number] => 166678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4208751 [patent_doc_number] => 06028109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Use of agonists of the peroxisome proliferator activated receptor alpha for treating obesity' [patent_app_type] => 1 [patent_app_number] => 9/155321 [patent_app_country] => US [patent_app_date] => 1998-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4202 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028109.pdf [firstpage_image] =>[orig_patent_app_number] => 155321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352850 [patent_doc_number] => 06190686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use' [patent_app_type] => 1 [patent_app_number] => 9/101456 [patent_app_country] => US [patent_app_date] => 1998-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6523 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190686.pdf [firstpage_image] =>[orig_patent_app_number] => 101456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238232 [patent_doc_number] => 06166049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Use of an antagonist of PPAR.alpha. and PPAR.gamma. for the treatment of syndrome X' [patent_app_type] => 1 [patent_app_number] => 9/101316 [patent_app_country] => US [patent_app_date] => 1998-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10978 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166049.pdf [firstpage_image] =>[orig_patent_app_number] => 101316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407521 [patent_doc_number] => 06172055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Apoptosis inhibitors for treating neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 9/137449 [patent_app_country] => US [patent_app_date] => 1998-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 4994 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172055.pdf [firstpage_image] =>[orig_patent_app_number] => 137449 [rel_patent_id] =>[rel_patent_doc_number] =>)